CD69 and prostate carcinoma: Others also found that CD69 deficient mice challenged with prostate carcinoma showed greatly reduced tumor growth and prolonged survival, which be due to the enhanced anti-tumor response of lymphocytes and increased lymphocytes in local (Esplugues et al., 2003).